Business Description
Affymax Inc
NAICS : 325412
SIC : 2834
ISIN : US00826A1097
Description
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S. It operates in one reportable segment, Marine Contracting.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 98.9 | |||||
9-Day RSI | 92.45 | |||||
14-Day RSI | 83.72 | |||||
3-1 Month Momentum % | -9.09 | |||||
6-1 Month Momentum % | 25 | |||||
12-1 Month Momentum % | 25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -19919.05 | |||||
OCF Margin % | -19919.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 0.03 | |||||
EV-to-EBIT | 0.02 | |||||
EV-to-EBITDA | 0.02 | |||||
EV-to-Revenue | 1.43 | |||||
EV-to-FCF | -0.01 | |||||
Earnings Yield (Greenblatt) % | 5000 | |||||
FCF Yield % | -13943.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AFFY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Affymax Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.042 | ||
| EPS (TTM) ($) | 0.06 | ||
| Beta | 4.45 | ||
| 3-Year Sharpe Ratio | 0.64 | ||
| 3-Year Sortino Ratio | 1.57 | ||
| Volatility % | 41.94 | ||
| 14-Day RSI | 83.72 | ||
| 14-Day ATR ($) | 0.000048 | ||
| 20-Day SMA ($) | 0.001175 | ||
| 12-1 Month Momentum % | 25 | ||
| 52-Week Range ($) | 0.0001 - 0.003 | ||
| Shares Outstanding (Mil) | 37.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Affymax Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Affymax Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Affymax Inc Frequently Asked Questions
What is Affymax Inc(AFFY)'s stock price today?
The current price of AFFY is $0.00. The 52 week high of AFFY is $0.00 and 52 week low is $0.00.
When is next earnings date of Affymax Inc(AFFY)?
The next earnings date of Affymax Inc(AFFY) is .
Does Affymax Inc(AFFY) pay dividends? If so, how much?
Affymax Inc(AFFY) does not pay dividend.
Guru Commentaries on OTCPK:AFFY
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Affymax Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers